aica ribonucleotide has been researched along with Endotoxin Shock in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bedard, N; Di Marco, S; Ford, RJ; Gallouzi, IE; Griss, T; Hall, DT; Jones, RG; Ma, JF; Mubaid, S; Omer, A; Pause, A; Sadek, J; Sanchez, BJ; Steinberg, GR; Tremblay, AMK; Wing, SS | 1 |
1 other study(ies) available for aica ribonucleotide and Endotoxin Shock
Article | Year |
---|---|
The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Animals; Cachexia; Cell Line; Enzyme Activation; Inflammation; Interferon-gamma; Male; Metformin; Mice, Inbred BALB C; Mitochondria; Muscle, Skeletal; Neoplasms, Experimental; Nitric Oxide Synthase Type II; Protein Kinases; Ribonucleotides; Shock, Septic; Tumor Necrosis Factor-alpha | 2018 |